EXPRS2.ST实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 23:29):

ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark...

Stats
今日成交量	34 344.00
平均成交量	124 252
市值	140.85M
EPS	SEK-0.443 ( 2023-11-16 )
下一个收益日期	( SEK0 ) 2024-05-30
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-1.040
ATR14	SEK0.0440 (1.61%)

音量相关性

長: 0.05 (neutral)

短: -0.13 (neutral)

Signal:(56.423) Neutral

ExpreS2ion Biotech 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

ExpreS2ion Biotech 相关性 - 货币/商品

0.37
( neutral )

0.24
( neutral )

0.00
( neutral )

0.05
( neutral )

-0.28
( neutral )

-0.13
( neutral )

ExpreS2ion Biotech 财务报表

Annual	2023
营收:	SEK8.80M
毛利润:	SEK5.15M (58.55 %)
EPS:	SEK-2.08

FY	2023
营收:	SEK8.80M
毛利润:	SEK5.15M (58.55 %)
EPS:	SEK-2.08

FY	2022
营收:	SEK5.09M
毛利润:	SEK5 000.00 (0.10 %)
EPS:	SEK-3.14

FY	2021
营收:	SEK12.23M
毛利润:	SEK4.72M (38.59 %)
EPS:	SEK-1.336

Financial Reports:

No articles found.

ExpreS2ion Biotech

ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark. The company develops capsid virus-like particle COVID-19 vaccine, which is in Phase II clinical trial. It also develops influenza and breast cancer vaccine, which is in Phase II clinical trial, as well as develops malaria vaccine. In addition, the company licenses its ExpreS2 platform to research institutes and pharmaceutical companies. ExpreS2ion Biotech Holding AB (publ) was founded in 2015 is based in Horsholm, Denmark.